Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pluristem Therapeutics Inc.    PSTI   US72940R1023

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
2.91(c) 2.94(c) 2.93(c) 2.94(c) 2.96 Last
62 009 154 457 59 528 75 064 8 452 Volume
-1.36% +1.03% -0.34% +0.34% +0.68% Change
More quotes
Company
Pluristem Therapeutics, Inc. is a bio-therapeutic company, which develops standardized cell therapy products for the treatment of life threatening diseases.The company's patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a... 
Surperformance© rating of Pluristem Therapeutics Inc
Trading Rating : Investor Rating :
More about the company
Chart PLURISTEM THERAPEUTICS INC
Duration : Period :
Pluristem Therapeutics Inc Technical Analysis Chart | PSTI | US72940R1023 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 0,25 M
EBIT 2015 -32,3 M
Net income 2015 -31,5 M
Debt 2015 -
Yield 2015 -
Sales 2016 7,90 M
EBIT 2016 -39,7 M
Net income 2016 -41,9 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 802x
Capi. / Sales 2016 25,8x
Capitalization 204 M
More Financials
Latest news on PLURISTEM THERAPEUTICS INC
2d ago PLURISTEM THERAPEUTICS : Case Western Reserve University to Study Pluristem's PL..
10/21 PLURISTEM THERAPEUTICS : Advances Its Second Major Cell Therapy Product Line Fro..
10/17 PLURISTEM THERAPEUTICS INC. : Pluristem's Therapy for Muscle and Tendon Regenera..
10/17 PLURISTEM THERAPEUTICS : Therapy for Muscle and Tendon Regeneration May Revoluti..
10/07 PLURISTEM THERAPEUTICS : Wins Cell Therapy Patent Case in Europe; European Paten..
10/01 PLURISTEM THERAPEUTICS : Coverage Initiation Report Focuses on Pluristem Therape..
09/11 PLURISTEM THERAPEUTICS : Termination of a Material Definitive Agreement (form 8-..
09/10 PLURISTEM THERAPEUTICS : to Deliver Scientific Presentations at 3rd Internationa..
09/08 PLURISTEM THERAPEUTICS : United Therapeutics Advances to Second Cohort in Phase ..
09/04 PLURISTEM THERAPEUTICS : to Present at Financial Conferences in New York City on..
07/31 PLURISTEM THERAPEUTICS : Israel's Ministry of Health Approves Pluristem's Commer..
07/22 PLURISTEM THERAPEUTICS : to Host Investor Breakfast and Webcast on July 23 in Ne..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF